NM_004104.5:c.5114G>A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_004104.5(FASN):c.5114G>A(p.Arg1705Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00019 in 1,572,120 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1705W) has been classified as Uncertain significance.
Frequency
Consequence
NM_004104.5 missense
Scores
Clinical Significance
Conservation
Publications
- neurodevelopmental disorderInheritance: AR Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FASN | ENST00000306749.4 | c.5114G>A | p.Arg1705Gln | missense_variant | Exon 30 of 43 | 1 | NM_004104.5 | ENSP00000304592.2 | ||
| FASN | ENST00000634990.1 | c.5108G>A | p.Arg1703Gln | missense_variant | Exon 30 of 43 | 5 | ENSP00000488964.1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152260Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000991 AC: 18AN: 181560 AF XY: 0.000114 show subpopulations
GnomAD4 exome AF: 0.000201 AC: 285AN: 1419742Hom.: 1 Cov.: 41 AF XY: 0.000202 AC XY: 142AN XY: 702010 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000853 AC: 13AN: 152378Hom.: 0 Cov.: 34 AF XY: 0.0000403 AC XY: 3AN XY: 74512 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.5114G>A (p.R1705Q) alteration is located in exon 30 (coding exon 29) of the FASN gene. This alteration results from a G to A substitution at nucleotide position 5114, causing the arginine (R) at amino acid position 1705 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Epileptic encephalopathy Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1705 of the FASN protein (p.Arg1705Gln). This variant is present in population databases (rs534878599, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with FASN-related conditions. ClinVar contains an entry for this variant (Variation ID: 531035). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at